VALBIOTIS SAS (ALVAL.PA) Stock Income Statement
EPA:ALVAL - Euronext Paris - Matif - FR0013254851 - Common Stock - Currency: EUR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 527.00K | 4.73M | 785.00K | 298.00K | 3.09M | |||
| Cost Of Goods | 3.23M | 2.42M | 561.00K | 417.00K | 568.00K | |||
| Gross Profit | -2.70M | 2.31M | 224.00K | -119.00K | 2.52M | |||
| Operating Expenses | 6.37M | 9.49M | 12.25M | 8.36M | 5.93M | |||
| Research and Development | 4.75M | 6.29M | 7.82M | 5.78M | 3.96M | |||
| Selling, General, and Administrative Expenses | 6.32M | 4.62M | 5.62M | 3.96M | 2.94M | |||
| Operating Income | -9.07M | -7.18M | -12.03M | -8.47M | -3.41M | |||
| Interest Income/Expense | -99.00K | -188.00K | -227.00K | -229.00K | -421.00K | |||
| Other Income/Expense | 218.00K | N/A | -61.00K | 23.00K | -1.00K | |||
| Income Before Taxes | -8.95M | -7.37M | -12.31M | -8.68M | -3.83M | |||
| Income Tax | N/A | N/A | -2.00K | N/A | N/A | |||
| Net Income | -8.94M | -7.37M | -12.31M | -8.68M | -3.83M | |||
| EBITDA | -7.52M | -6.44M | -11.17M | -7.53M | -2.37M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.66 | -0.59 | -1.22 | -0.95 | -0.51 | |||
| Statistics | ||||||||
| Gross Profit Margin | -511.95% | 48.76% | 28.54% | -39.93% | 81.63% | |||
| Profit Margin | -1697.15% | -155.67% | -1568.41% | -2913.09% | -123.84% | |||
| Operating Profit Margin | -1721.06% | -151.70% | -1531.97% | -2843.96% | -110.19% | |||
All data in EUR